BLIGHT ANDREW R.,CAGGIANO ANTHONY O.,PARRY TOM J.,IACI JENNIFER F.
申请号：
NZ62325512
公开号：
NZ623255A
申请日:
2012.10.04
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
Disclosed herein the therapeutic use of aminopyridines in patients with a stroke-related impairment, in particular, in patients with a stroke-related sensorimotor impairment, wherein the stroke-related sensorimotor impairment is an impairment in walking, impairment in limb function, impairment in lower extremity function, impairment in upper extremity function, impairment in hand function, impairment in fine hand coordination, impairment in grip strength, impairment in balance or coordination, impairment in global body control, dysarthria, impairment in jaw function, impairment in chewing, or impairment in jaw articulation. In particular embodiments, the aminopyridines used are 3-aminopyridine, 4-aminopyridine, or 3,4-diaminopyridine.
